MedPath

Cefazolin

CEFAZOLIN FOR INJECTION, USP

Approved
Approval ID

570d2583-9ce7-4941-bf7c-6ebc783c0f2b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 15, 2018

Manufacturers
FDA

West-Ward Pharmaceuticals Corp

DUNS: 001230762

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cefazolin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0143-9261
Application NumberANDA065143
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefazolin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 17, 2018
FDA Product Classification

INGREDIENTS (1)

CEFAZOLIN SODIUMActive
Quantity: 10 g in 1 1
Code: P380M0454Z
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cefazolin - FDA Drug Approval Details